Skip to content
Open access

Whole-Genome Analysis, Biosynthetic Gene Cluster Mining of Amycolatopsis sp. nov. TRM77291 and Antibacterial Activity of Siderochelin A

Sep 2026 · Microorganisms · Vol 14 · 0 citations · 23 references
Medicine

TL;DR

Siderochelin A, a monomeric compound isolated from a fermentation product, demonstrated antibacterial efficacy against various pathogenic bacteria, providing a theoretical basis for discovering novel species, exploring secondary metabolites, and developing innovative antibiotics.

Abstract

The genus Amycolatopsis, belonging to the phylum Actinobacteria, is known for producing diverse bioactive secondary metabolites and plays a significant role in microbial drug discovery. This study centers on the strain TRM77291, sourced from a unique habitat, and is postulated to represent a potential new species. This hypothesis is based on 16S rRNA gene phylogenetic analysis combined with physiological, biochemical, and chemotaxonomic characterization. The strain’s genome, consisting of 8.76 Mb with a G + C content of 68.89% and encoding 8572 genes, was analyzed through whole-genome sequencing. AntiSMASH analysis identified 38 biosynthetic gene clusters related to PKS, NRPS, and RiPPs, while BIG-SCAPE analysis indicated the potential for unique compound synthesis, including Cluster 7 and Cluster 35. Screening ten fermentation media determined millet medium as the most optimal choice. Siderochelin A, a monomeric compound isolated from a fermentation product, demonstrated antibacterial efficacy against various pathogenic bacteria. This study revealed a notable activity of Siderochelin A against Escherichia coli, providing a theoretical basis for discovering novel species, exploring secondary metabolites, and developing innovative antibiotics.

Read PDF

Similar papers

Open access Sep 2026

Comparative Genomics of Paenibacillus Secondary Metabolism: Unveiling the Putative Biosynthetic Gene Cluster for Paenialvins in Paenibacillus Alvei Strain 32.

The putative biosynthetic pathway of the paenialvins is described and structural variations are explained, bringing useful data on Paenibacillus secondary metabolism for future antibiotic development.

Drago Haas, Fatoumata Tambadou, T. Caradec et al. · 0 citations
Sep 2026

Whole-genome analysis of Brevibacterium sanguinis AZMABM HM27: a bacterial isolate from the sea anemone Radianthus magnifica and exhibiting promising multi-therapeutic properties

B. sanguinis AZMABM HM27 represents a marine symbiotic strain associated with R. magnifica and a promising source of bioactive compounds with antioxidant, anti-inflammatory, antidiabetic, and antiproliferative potential.

B. Manguntungi, Feraliana Feraliana, Azzahra Khasna Ramaniya et al. · 0 citations
Open access Sep 2026

Whole-genome sequencing and genomic analysis of the Bacillus licheniformis strain MGMM137 as a potential bioremediation agent for contaminated soils

Bacillus licheniformis  species produce a wide array of secondary metabolites and are recognized for their high tolerance to toxins and heavy metals, making them promising bacterial biocontrol agents in agriculture, industry, and medicine. In this study, the complete genome of the  Bacillus licheniformis  strain M...

A. Y. Sukhanov, I. V. Nekrasov, S. Validov · 0 citations
Open access Sep 2026

Comparative Genome Mining of Jiangella sp. GA3 from Turtle-Ingested Plastic Reveals Conserved Biosynthetic Gene Clusters

The isolation of a novel Jiangella strain reported from a marine, animal-associated plastisphere is described and its biosynthetic repertoire is placed in the context of the whole genus, providing a genome-based prioritization of candidate biosynthetic targets.

Ruggero Baviera, F. Capri, Paola Galluzzo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.